Fda to Review Merck Diabetes Drug ; Could Be Available by Year's End

The Record, Bergen County, NJ › February 17, 2006

Linked as:

Summary

Merck & Co. said Thursday that the U.S. Food and Drug Administration will review its application for an experimental oral diabetes treatment, giving the company a leg up on the competition.

An FDA review typically takes 10 months, which means Merck's Januvia treatment for Type 2 diabetes could be available before the end of the year.

See the full content of this document

Extract

Fda to Review Merck Diabetes Drug ; Could Be Available by Year's End

Whitehouse Station-based Merck said it plans to seek approval for Januvia outside th...

See the full content of this document